SASH3 variants cause a novel form of X-linked combined immunodeficiency with immune dysregulation.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
23 09 2021
Historique:
pubmed: 21 4 2021
medline: 15 12 2021
entrez: 20 4 2021
Statut: ppublish

Résumé

Sterile alpha motif (SAM) and Src homology-3 (SH3) domain-containing 3 (SASH3), also called SH3-containing lymphocyte protein (SLY1), is a putative adaptor protein that is postulated to play an important role in the organization of signaling complexes and propagation of signal transduction cascades in lymphocytes. The SASH3 gene is located on the X-chromosome. Here, we identified 3 novel SASH3 deleterious variants in 4 unrelated male patients with a history of combined immunodeficiency and immune dysregulation that manifested as recurrent sinopulmonary, cutaneous, and mucosal infections and refractory autoimmune cytopenias. Patients exhibited CD4+ T-cell lymphopenia, decreased T-cell proliferation, cell cycle progression, and increased T-cell apoptosis in response to mitogens. In vitro T-cell differentiation of CD34+ cells and molecular signatures of rearrangements at the T-cell receptor α (TRA) locus were indicative of impaired thymocyte survival. These patients also manifested neutropenia and B-cell and natural killer (NK)-cell lymphopenia. Lentivirus-mediated transfer of the SASH3 complementary DNA-corrected protein expression, in vitro proliferation, and signaling in SASH3-deficient Jurkat and patient-derived T cells. These findings define a new type of X-linked combined immunodeficiency in humans that recapitulates many of the abnormalities reported in mice with Sly1-/- and Sly1Δ/Δ mutations, highlighting an important role of SASH3 in human lymphocyte function and survival.

Identifiants

pubmed: 33876203
pii: S0006-4971(21)00893-4
doi: 10.1182/blood.2020008629
pmc: PMC8462359
doi:

Substances chimiques

Receptors, Antigen, T-Cell, alpha-beta 0

Types de publication

Clinical Trial Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1019-1033

Subventions

Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA AI001222
Pays : United States

Informations de copyright

© 2021 by The American Society of Hematology.

Références

Blood Adv. 2020 Jun 23;4(12):2611-2616
pubmed: 32556283
Sci Signal. 2013 Oct 15;6(297):ra92
pubmed: 24129702
J Clin Immunol. 2020 Jan;40(1):24-64
pubmed: 31953710
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W382-8
pubmed: 15980494
Nat Immunol. 2002 May;3(5):469-76
pubmed: 11967541
Mol Cell Biol. 2005 Nov;25(21):9646-60
pubmed: 16227612
Nat Metab. 2019 Jul;1(7):717-730
pubmed: 32373781
Nat Med. 2000 May;6(5):543-8
pubmed: 10802710
J Biol Chem. 2003 Mar 14;278(11):9267-75
pubmed: 12515807
Biochim Biophys Acta. 2001 Jul 30;1520(1):89-93
pubmed: 11470164
J Allergy Clin Immunol. 2019 Jun;143(6):2317-2321.e12
pubmed: 30822429
J Allergy Clin Immunol. 2015 Jun;135(6):1578-88.e5
pubmed: 25842288
Nat Immunol. 2016 Aug;17(8):946-55
pubmed: 27348411
Nucleic Acids Res. 2018 Jan 4;46(D1):D428-D434
pubmed: 29136216
BMC Immunol. 2009 Jul 15;10:38
pubmed: 19604361
Eur J Immunol. 2015 Nov;45(11):3087-97
pubmed: 26306874
Oncoimmunology. 2016 Sep 27;5(12):e1238543
pubmed: 28123874
Nucleic Acids Res. 2015 Jan;43(Database issue):D512-20
pubmed: 25514926
Nat Methods. 2016 Feb;13(2):109-10
pubmed: 26820543
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Sci Rep. 2019 Jan 10;9(1):54
pubmed: 30631134
Mol Immunol. 2009 Feb;46(5):969-77
pubmed: 18950867
Int J Mol Sci. 2018 Dec 20;20(1):
pubmed: 30577453
J Allergy Clin Immunol. 2019 Jan;143(1):325-334.e2
pubmed: 29906526
J Allergy Clin Immunol. 2019 Jul;144(1):333-336
pubmed: 31053347
N Engl J Med. 2008 May 8;358(19):2030-8
pubmed: 18463379
J Allergy Clin Immunol. 2017 Apr;139(4):1302-1310.e4
pubmed: 27658761
Front Immunol. 2017 Jul 17;8:798
pubmed: 28769923
J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1412-1420
pubmed: 30869812
Sci Immunol. 2020 Jul 24;5(49):
pubmed: 32709702
Science. 2015 Aug 7;349(6248):606-613
pubmed: 26160376
J Allergy Clin Immunol. 2015 Oct;136(4):993-1006.e1
pubmed: 26162572
Nat Immunol. 2014 Sep;15(9):798-807
pubmed: 25137454
Bioinformatics. 2017 May 1;33(9):1402-1404
pubmed: 28453683
Nat Immunol. 2010 Feb;11(2):162-70
pubmed: 20010845
Blood. 2018 May 24;131(21):2335-2344
pubmed: 29653965
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W597-600
pubmed: 23671338
Nat Protoc. 2012 Jul 19;7(8):1511-22
pubmed: 22814390

Auteurs

Ottavia M Delmonte (OM)

Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Jenna R E Bergerson (JRE)

Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Tomoki Kawai (T)

Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Hye Sun Kuehn (HS)

Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.

David H McDermott (DH)

Molecular Signaling Section, Laboratory of Molecular Immunology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Irene Cortese (I)

Neuroimmunology Clinic, Division of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.

Michael T Zimmermann (MT)

Division of Research, Genomics Sciences & Precision Medicine Center, Milwaukee, WI.
Clinical and Translational Sciences Institute, Medical College of Wisconsin, Milwaukee, WI.

A Kerry Dobbs (AK)

Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Marita Bosticardo (M)

Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Danielle Fink (D)

Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD.

Shamik Majumdar (S)

Molecular Signaling Section, Laboratory of Molecular Immunology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Boaz Palterer (B)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Francesca Pala (F)

Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Nikita R Dsouza (NR)

Division of Research, Genomics Sciences & Precision Medicine Center, Milwaukee, WI.

Marie Pouzolles (M)

Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Naomi Taylor (N)

Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Institut de Genetique Moleculaire de Montpellier, Centre National de la Recherche Scientifique Unité Mixte de Recherche (UMR) 5535, Universite de Montpellier, Montpellier, France.

Katherine R Calvo (KR)

Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.

Stephen R Daley (SR)

Centre for Immunology and Infection Control, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia.

Daniel Velez (D)

Molecular Signaling Section, Laboratory of Molecular Immunology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Anahita Agharahimi (A)

Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Katherine Myint-Hpu (K)

Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Lesia K Dropulic (LK)

Laboratory of Infectious Disease and.

Jonathan J Lyons (JJ)

Division of Intramural Research, Laboratory of Allergic Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD and.

Steven M Holland (SM)

Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Alexandra F Freeman (AF)

Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Rajarshi Ghosh (R)

Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Morgan B Similuk (MB)

Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Julie E Niemela (JE)

Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.

Jennifer Stoddard (J)

Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.

Douglas B Kuhns (DB)

Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD.

Raul Urrutia (R)

Division of Research, Genomics Sciences & Precision Medicine Center, Milwaukee, WI.
Department of Surgery, Medical College of Wisconsin, Milwaukee, WI.

Sergio D Rosenzweig (SD)

Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.

Magdalena A Walkiewicz (MA)

Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Philip M Murphy (PM)

Molecular Signaling Section, Laboratory of Molecular Immunology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Luigi D Notarangelo (LD)

Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH